Home Register Abstracts Program FAQ

Schedule

18th Immunology of Diabetes (IDS) Congress Program

Monday, November 1, 2021 – Thursday, November 4, 2021

Virtual Program (v. September 12, 2021)

All times shown are in Coordinated Universal Time (UTC/GMT).
Daylight savings will occur for some countries surrounding the dates of the conference. To determine your local time, please utilize a world clock converter and adjust the date to account for daylight savings time (example)

Monday, November 1, 2021

19:00 – 19:05

Welcome (5 minutes)

19:05 – 19:35

Plenary Lecture: Current state of T1D Rx and outcomes – closed loop/pumps/sensors - David Maahs (30 minutes)

19:35 – 20:55

Symposium A: Next generation of T1D staging

  • Beyond the stages: IBM longitudinal data sets in TEDDY – Peter Achenbach (20 minutes)
  • TrialNet omics CMSP data – Eion McKinney and Dirk Homann (20 minutes)
  • Risk progression in TrialNet – Emily Sims (20 minutes)
  • Discussion (20 minutes)

20:55 – 21:10

Break (15 minutes)

21:10 – 22:30

Symposium B: Islet – Immune Interactions:

  • T1D insights from Human Pancreas Analysis Program - Klaus Kaestner (20 minutes)
  • Plasticity in human pancreas and islets and immune system in early life - Diane Saunders (20 minutes)
  • Lymphocytes from islets and pancreatic lymph nodes - Mike Betts (20 minutes)
  • Discussion (20 minutes)

22:30

Adjourn

Tuesday, November 2, 2021

19:00 – 19:30

Plenary Lecture: Beta cells from stem cells - Doug Melton

(30 minutes)

19:30 – 20:45

Symposium C: Potential pathogenic mechanisms in T1D

  • Regulatory T cell signatures – Carolin Daniel (15 minutes)
  • “Sterile Inflammation” - Yuval Dor (15 minutes)
  • Beta cell stress responses and senescence in T1D – Peter Thompson (15 minutes)
  • Lessons from animal models - Helen Thomas (15 minutes)
  • Discussion (15 minutes)

20:45 – 20:55

Break (10 minutes)

20:55 – 21:20

  • Selected abstracts for oral presentation (20 minutes) 4 abstracts (5 minute presentation)

21:20 – 22:30

  • Poster Session (80 minutes)

22:30

Adjourn


Wednesday, November 3, 2021

19:00 – 19:30

Plenary Lecture (30 minutes)

19:30 – 20:30

Symposium D: Lessons from other diseases

  • CD8 T cell programming in cancer and beta cells - Benjamin Youngblood (15 minutes)
  • Endotypes in Allergic Diseases/Asthma - Ioana Octavia Agache (15 minutes)
  • CAR-Treg therapy in transplantation, lessons for T1D - Megan Levings
  • Discussion (15 minutes)

20:30 – 21:30

Special Symposium: T1D interventions – industry perspectives (60 minutes; 8 minutes/speaker)

  • Discussion (20 minutes)

21:30 – 21:45

Break (15 minutes)

21:45 – 22:45

Symposium E: Clinical trials consideration

  • Responder signatures: Alice Long (15 minutes)
  • Combination therapy: Linda Dimeglio (15 minutes)
  • TBD (15 minutes)
  • Discussion (15 minutes)

22:45

Adjourn

Thursday, November 4, 2021

19:00 – 19:30

Plenary Lecture (30 minutes)

19:30 – 20:50

Symposium F: Genetics and other omics - present and future

  • New avenues for exploring the genetics of T1D - Kyle Gaulton (15 minutes)
  • Genetic influences in T1D - Lorenzo Pasquali (15 minutes)
  • Integrating omics into biomarkers of T1D - David Leslie (15 minutes)
  • Role of genetics in forming the microbiome in T1D – Eric Triplett (15 minutes)
  • Discussion (20 minutes)

20:50 – 21:05

Break (15 minutes)

21:05 – 22:05

Debate Future Therapies for T1D in 5 years, 10 years, and 20 years?

  • Mechanical: Chantal Mathieu (10 minutes)
  • Cell transplantation: Tom Kay (10 minutes)
  • Immunomodulation: Mark Anderson (10 minutes)
  • Discussion (30 minutes)

22:05 – 22:20

Meeting Summary and Looking Forward - Ezio Bonifacio, Marcela Brissova, Chantal Mathieu (Representing views on immunology, beta cells, industry)

22:20 – 22:30

Closing Comments